Must-Know Finance Concepts for Life Sciences Valuations

This webinar presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.

If you are an entrepreneur who is, or will be, raising financing, licensing an asset or selling your company, a private investor who wants to estimate and negotiate start-up share value, or any other professional who is active in the investing sector, you'll benefit from this overview of the key concepts used in life sciences valuation discussions.

You'll learn:

  • The various valuation methodologies used to assign a value to life science businesses and assets
  • The methodologies used in particular by pharma partners and venture capitalists
  • An explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital and present value

watch the  webinar 


Company team

John Selig 

Co-Founder and Managing Partner of WaveEdge Capital

John advises life sciences companies on M&A, licensing and financial strategy. He teaches the valuation and finance module at BIO’s Executive Management course for BD professionals and at Stanford Medical School’s Entrepreneurship program. Learn More  

Company team

Jeff Karan 

Co-Founder and Managing Partner of WaveEdge Capital  

Jeff brings over 30 years of investment banking and corporate advisory experience to WaveEdge Capital.  In addition to his extensive knowledge of capital raising and merger & acquisitions, Jeff has advised clients on corporate strategy, business valuation, and a wide range of strategic partnership structures.  Learn More